A new study investigated whether the structure of the 340B Drug Pricing Program inhibits the use of biosimilar medications, which are medically equivalent but not identical to original biologic drugs due to production differences.
Big Red Ventures (BRV), Cornell University’s early-stage venture capital fund run by MBAs and other graduate students, presented its portfolio and announced a new investment during the Annual Meeting on April 18 at Cornell Tech.
One in six assisted living facility residents is subject to verbal, physical or other aggression by a fellow resident in a typical month, according to the first large-scale study of the phenomenon.
Together, Matt Hall, Parfait Eloundou-Enyegue, and their faculty colleagues at the Cornell Population Center are pushing the traditional limits of their disciplines to find creative ways to meet a generation that could be defined by major population transformations. This includes leveraging demographic and big data tools to analyze how older populations navigate their communities, how racial diversity shapes patterns of marriage and childbearing, and how accelerating migration may undermine repressive political regimes.
Mario Herrero, Timothy Ryan, M.S. ’86, Ph.D. ’89, Steven Strogatz and Peter Wolczanski are Cornell’s 2024 electees to the National Academy of Sciences, the academy announced April 30 at the close of its 161st annual meeting.
Severe COVID-19 infection triggers changes that affect gene expression in immune system stem cells, causing alterations in the body’s immune response, according to a new study by Weill Cornell Medicine and Jackson Laboratory investigators.
With the city as both setting and subject, AAP's new graduate program prepares students to address pressing urban, environmental, and social issues using the tools of design.